JP2022534420A5 - - Google Patents
Info
- Publication number
- JP2022534420A5 JP2022534420A5 JP2021570895A JP2021570895A JP2022534420A5 JP 2022534420 A5 JP2022534420 A5 JP 2022534420A5 JP 2021570895 A JP2021570895 A JP 2021570895A JP 2021570895 A JP2021570895 A JP 2021570895A JP 2022534420 A5 JP2022534420 A5 JP 2022534420A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- alkyl
- hydrogen
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962855560P | 2019-05-31 | 2019-05-31 | |
| US62/855,560 | 2019-05-31 | ||
| PCT/US2020/035592 WO2020243720A1 (en) | 2019-05-31 | 2020-06-01 | Pharmacological agents for treating protein aggregation diseases of the eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022534420A JP2022534420A (ja) | 2022-07-29 |
| JP2022534420A5 true JP2022534420A5 (https=) | 2023-06-09 |
Family
ID=73553335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570895A Pending JP2022534420A (ja) | 2019-05-31 | 2020-06-01 | 眼のタンパク質凝集疾患を治療するための薬剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220241247A1 (https=) |
| EP (1) | EP3976017A4 (https=) |
| JP (1) | JP2022534420A (https=) |
| CN (1) | CN114173771A (https=) |
| BR (1) | BR112021024151A2 (https=) |
| CA (1) | CA3141998A1 (https=) |
| MX (1) | MX2021014682A (https=) |
| WO (1) | WO2020243720A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4097092A1 (en) * | 2020-01-28 | 2022-12-07 | Protego Biopharma, Inc. | Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| US20250019352A1 (en) * | 2021-06-29 | 2025-01-16 | Plex Pharmaceuticals, Inc. | Pharmacological agents for treating ophthalmic diseases |
| WO2023009585A2 (en) * | 2021-07-28 | 2023-02-02 | Protego Biopharma, Inc. | Transthyretin stabilizing compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005113523A1 (en) * | 2004-05-20 | 2005-12-01 | Foldrx Pharmaceuticals, Inc. | 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| WO2011116123A1 (en) * | 2010-03-19 | 2011-09-22 | Irm Llc | Tafamidis for the treatment of ophthalmic diseases |
| RU2586330C2 (ru) * | 2011-09-16 | 2016-06-10 | Пфайзер Инк. | Твердые формы ингибитора диссоциации транстиретина |
| RU2747536C2 (ru) * | 2011-10-24 | 2021-05-06 | Сом Инновэйшн Биотек, С.Л. | Новая терапия транстиретин-ассоциированного амилоидоза |
| US9499527B2 (en) * | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
| US9169214B2 (en) * | 2012-12-21 | 2015-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
| US9790269B2 (en) * | 2013-02-08 | 2017-10-17 | Misfolding Diagnostics, Inc. | Transthyretin antibodies and uses thereof |
| RU2015138891A (ru) * | 2013-03-08 | 2017-04-11 | Аллерган, Инк. | Конъюгаты антибиотиков, напрямую связанные со стероидными препаратами |
| PE20151747A1 (es) * | 2013-03-14 | 2015-12-18 | Univ Massachusetts | Metodo para inhibir cataratas y presbicia |
| US11872236B2 (en) * | 2018-04-05 | 2024-01-16 | Calasia Pharmaceuticals, Inc. | Pharmacological agents for treating ocular diseases |
-
2020
- 2020-06-01 CA CA3141998A patent/CA3141998A1/en active Pending
- 2020-06-01 CN CN202080054595.2A patent/CN114173771A/zh active Pending
- 2020-06-01 US US17/615,469 patent/US20220241247A1/en not_active Abandoned
- 2020-06-01 JP JP2021570895A patent/JP2022534420A/ja active Pending
- 2020-06-01 EP EP20813466.8A patent/EP3976017A4/en active Pending
- 2020-06-01 WO PCT/US2020/035592 patent/WO2020243720A1/en not_active Ceased
- 2020-06-01 BR BR112021024151A patent/BR112021024151A2/pt not_active Application Discontinuation
- 2020-06-01 MX MX2021014682A patent/MX2021014682A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022534420A5 (https=) | ||
| Bousquet et al. | Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber | |
| RU2011103741A (ru) | Композиции и способы лечения заболевания сетчатки | |
| RU2005135016A (ru) | Производные хинолина в качестве ингибиторов фосфодиэстеразы | |
| JP2022000482A5 (https=) | ||
| KR102292206B1 (ko) | 티로신 유도체 및 이를 포함하는 조성물 | |
| JP2023546565A5 (https=) | ||
| JP2009542815A5 (https=) | ||
| JP2017502073A5 (https=) | ||
| JP2008512426A5 (https=) | ||
| JPH06100446A (ja) | （Ｓ）−α−フルオロメチル−ヒスチジン及びそのエステルを使用するぜん息の治療方法 | |
| JP2009538327A5 (https=) | ||
| EA200900827A1 (ru) | Фармацевтический состав, содержащий антагонист нейрокининов | |
| CN111295202A (zh) | 治疗甲癣的外用制剂 | |
| JP2019515040A5 (https=) | ||
| JP2003522198A5 (https=) | ||
| JP2024541569A5 (https=) | ||
| JP2002525318A (ja) | 眼、耳および鼻治療用の抗生物質組成物 | |
| US20120027842A1 (en) | Topical formulations of flap inhibitors for administration to an eye | |
| JP2025508359A5 (https=) | ||
| EP2983788A1 (en) | The local treatment of inflammatory ophthalmic diseases | |
| RU99121654A (ru) | Средства для предотвращения или лечения болезней, связанных с чрезмерной пролиферацией эпителиальных пигментных клеток сетчатки | |
| JP2007527417A5 (https=) | ||
| JP2005508341A5 (https=) | ||
| JP2021503451A5 (https=) |